Adlai Nortye Group Ltd.
ANL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001944552
In the last 90 days, Adlai Nortye Group Ltd. insiders filed 0 open-market purchases and 3 sales; 42 institutions reported holding it in 13F filings for Q2 2026, worth $304.3M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Adlai Nortye Group Ltd. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 3 | 3 | 0 |
| Shares | 59.0K | 63.7K | +4.64K (+7.9%) |
| Value | $196.8K | $126.7K | −$70.1K (−35.6%) |
New holders (1)
Institutions that held Adlai Nortye Group Ltd. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 1,138 | $2.26K | 0.00% |
Sold out (1)
Institutions that held Adlai Nortye Group Ltd. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Qube Research & Technologies Ltd | 88 | $307 |